- Home
- ATAI vs GHLD Comparison
ATAI vs GHLD Comparison
Compare ATAI & GHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- GHLD
- Stock Information
- Founded
- ATAI 2018
- GHLD 1960
- Country
- ATAI Netherlands
- GHLD United States
- Employees
- ATAI N/A
- GHLD N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- GHLD Finance: Consumer Services
- Sector
- ATAI Health Care
- GHLD Finance
- Exchange
- ATAI Nasdaq
- GHLD Nasdaq
- Market Cap
- ATAI 1.1B
- GHLD 1.2B
- IPO Year
- ATAI 2021
- GHLD 2020
- Fundamental
- Price
- ATAI $5.88
- GHLD $19.86
- Analyst Decision
- ATAI Strong Buy
- GHLD Hold
- Analyst Count
- ATAI 5
- GHLD 6
- Target Price
- ATAI $14.00
- GHLD $18.10
- AVG Volume (30 Days)
- ATAI 7.1M
- GHLD 28.3K
- Earning Date
- ATAI 11-14-2025
- GHLD 11-07-2025
- Dividend Yield
- ATAI N/A
- GHLD 3.78%
- EPS Growth
- ATAI N/A
- GHLD N/A
- EPS
- ATAI N/A
- GHLD 0.42
- Revenue
- ATAI $2,309,000.00
- GHLD $1,125,872,000.00
- Revenue This Year
- ATAI $736.04
- GHLD $1.42
- Revenue Next Year
- ATAI N/A
- GHLD $22.36
- P/E Ratio
- ATAI N/A
- GHLD $47.60
- Revenue Growth
- ATAI 510.85
- GHLD 23.19
- 52 Week Low
- ATAI $1.04
- GHLD $11.21
- 52 Week High
- ATAI $6.75
- GHLD $23.57
- Technical
- Relative Strength Index (RSI)
- ATAI 52.01
- GHLD 48.35
- Support Level
- ATAI $5.50
- GHLD $19.77
- Resistance Level
- ATAI $6.23
- GHLD $19.93
- Average True Range (ATR)
- ATAI 0.46
- GHLD 0.07
- MACD
- ATAI -0.06
- GHLD -0.01
- Stochastic Oscillator
- ATAI 26.71
- GHLD 47.83
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About GHLD Guild Holdings Company
Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.